trc093

mAbexperimental

Clinical trial activity

1 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Jun 1, 2007 (NCT00492830)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No
Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • mt-293
  • trc093
  • trc093
  • trc-093

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00492830Phase 1Jun 1, 2007Tracon Pharmaceuticals Inc.
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Tracon Pharmaceuticals Inc.For profit1112007
1 organizations
Page 1 / 1